Development of positron emission tomography technologies for cancer diagnosis and new drugs development

Tavernier, Stefaan (Administrative Promotor)
Bossuyt, Axel (Co-Promotor)
Bruyndonckx, Peter, (Co-Promotor)
Defrise, Michel (Co-Promotor)
Mertens, John (Co-Promotor)

Description

Development of positron emission tomography technologies for cancer diagnosis and new drugs development

not available

Acronym	OZR1715
Status	Finished
Effective start/end date	1/01/08 → 31/12/08

Flemish discipline codes

Biological sciences

Keywords

physics

3 Article

123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients
Keyaerts, M., Lahoutte, T., Neyns, B., Caveliers, V., Vanhove, C., Everaert, H., Kersemans, K., Franken, P. R., Mertens, J. & Bossuyt, A., Jul 2007, In : European Journal of Nuclear Medicine and Molecular Imaging. 34, 7, p. 994-1002 9 p.
Research output: Contribution to journal › Article
11 Citations (Scopus)
D- and L-[I-123]-2-I-phenylalanineshow a long tumour retention compared with D- and L-[I-123]2-I-tyrosine in RIM rhabdomyosarcoma tumour-bearing Wag/Rij rats
Bauwens, M., Lahoutte, T., Kersemans, K., Caveliers, V., Bossuyt, A. & Mertens, J., 2007, In : Contrast Media & Molecular Imaging. 2, 4, p. 172-177 5 p.
Research output: Contribution to journal › Article
Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine
Bauwens, M., Keyaerts, M., Lahoutte, T., Kersemans, K., Caveliers, V., Bossuyt, A. & Mertens, J., 2007, In : Nuclear Medicine Communications. 28, 10, p. 823-828 6 p.
Research output: Contribution to journal › Article
6 Citations (Scopus)